Estimated Time to Complete
Only available after login
What You'll Learn
Concepts:
Karma and Rebirth Cycle
Home-Based Care as an Alternative to Inpatient Stem Cell Transplant
An Oncologist's Reflections on Practicing Medicine During the COVID-19 Pandemic
Adjuvant Chemotherapy Selection for Stage II and III Colorectal Cancer During the COVID-19 Pandemic
Medicaid Expansion and Racial Disparities in Time to Cancer Treatment in Health Policy
Increased Atrial Fibrillation Risk After Early-Stage Breast Cancer Diagnosis
Pembrolizumab Treatment for Advanced Esophageal Cancer
Atopic Dermatitis in Pediatric Patients with Skin of Color
Self-Reporting Web App for Lung Cancer Patients
Compassionate Communication With Patients in Oncology Care
National Lung Cancer Screening Guidelines Underclassify Younger African American Patients
Updated ASCO Guidelines for Venous Thromboembolism Prophylaxis in Cancer Patients
Deciding Whether to Delay Lung Cancer Treatment During the COVID-19 Pandemic
Choosing Immunotherapy Regimens by PD-L1 Status in Metastatic Non-Small Cell Lung Cancer
Ribociclib plus endocrine therapy boosts survival of HR+/HER2- breast cancer
Racial Disparities in Chemotherapy Use and Survival for Extensive-Stage Small Cell Lung Cancer
Reducing Time to Treatment for Newly Diagnosed Cancer Patients in Oncology Care Delivery
Stem Cell Survival in Bone Marrow After Chemotherapy
Hepatitis B Screening and Reactivation Risk in Cancer Therapy
Excess Radiation Dose in Low-Dose CT Lung Cancer Screening
Preventing Burnout Through Outside Interests in Oncology Practice
Robot-Assisted Partial Nephrectomy Reduces Complications in Renal Cell Cancer Surgery
Subcutaneous vs Intravenous Daratumumab Non-Inferiority Trial in Multiple Myeloma
PSMA PET/CT Versus Conventional Imaging for High-Risk Prostate Cancer Staging
Sorafenib Plus GCLAM Achieves an 83% Complete Response Rate in AML and MDS
Umbralisib Plus Ibrutinib Response Rates in Mantle Cell Lymphoma and CLL
Navigating Family Requests to Withhold a Cancer Diagnosis from the Patient
Insights from International T-Cell Lymphoma Patient Registries
2019 FDA Drug Approvals in Hematology-Oncology
FDA approves combo immunotherapy for mesothelioma, atezolizumab strikes out in ovarian cancer,...
Why the TMIST Mammography Trial Failed to Enroll Patients in Clinical Oncology
CHOEP Regimen Favored by Registry Data for Peripheral T-Cell Lymphoma
Evolving Treatment Regimens for Acute Myeloid Leukemia in Older Adults
Rigosertib Plus Azacitidine Combination Dosing for Higher-Risk Myelodysplastic Syndrome
Pharmaceutical Returns on Cancer Drug R&D Investment
NPM1 DNMT3A and FLT3-ITD Mutation Status for Risk Stratification in Normal Karyotype AML
Lowering the Age Threshold for Low-Dose CT Lung Cancer Screening Eligibility
American College of Physicians Colorectal Cancer Screening Guidelines for Average-Risk Adults
The Role of the Palliative Care Team in Cancer Treatment
ASCO President's Vision for Uniting Stakeholders in Oncology
Recent Clinical Trial Advances in HER2-Positive and Triple-Negative Breast Cancer Treatment
Breast Cancer Risk Associated with Hormone Replacement Therapy in Oncology
Using CRISPR Gene Editing to Overcome Fratricide in CAR T-Cell Therapy for T-Cell Malignancies
Epigenetic Drug Targets in T-Cell Lymphoma Treatment
ASCO Guidelines for Antiemetic Prophylaxis in Chemotherapy Patients
Obesity and Rising Cancer Rates in Young Adults
Interpreting Post Hoc Subgroup Analyses in Clinical Trial Data
Venous Thromboembolism and Coagulopathy in COVID-19 Patients
New Therapies for AML, Polycythemia Vera, and Myeloma in Hematology-Oncology
Discussing the Shift from Curative to Palliative Cancer Care When Family Wants to Continue Treatment
Margin Status and Resection Technique in Duodenal Neuroendocrine Tumor Recurrence
Financial Toxicity in Cancer Treatment Decisions
Delaying Radiotherapy After Androgen Deprivation Therapy for High-Risk Prostate Cancer
Predicting Heart Failure Risk in Type 2 Diabetes with the WATCH-DM Score
Adjuvant Osimertinib for Resected EGFR-Mutated Non-Small Cell Lung Cancer in Oncology
Local Regional Management of Early-Stage Breast Cancer in Oncology
MRI Detection of Clinically Significant Prostate Cancer
Recommender System Algorithm for Predicting Lenalidomide Response in Myelodysplastic Syndrome
Data Gaps on Transgender Patients in Leukemia Research
Discussing Prognosis with Terminal Cancer Patients in Oncology
Monitoring Cardiotoxicity From Breast Cancer Therapies in Cardio-Oncology
Differential Diagnosis of Acute Thrombocytopenia in Hematology
2020 San Antonio Breast Cancer Symposium Research Highlights
Increased Second Malignancy Risk in Mycosis Fungoides Patients in Oncology
Cognitive Behavioral Therapy for Depression and Anxiety in Cancer Patients
Post-Transplant Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Allogeneic Transplant
Cobomarsen Clinical Trial Results for Adult T-Cell Leukemia/Lymphoma
PD-L1 Testing and Immunotherapy Selection in Non-Small-Cell Lung Cancer
Roxadustat as a HIF-1α Stabilizer for Anemia in Myelodysplastic Syndrome
Biosimilars in Clinical Hematology and Oncology
Avoiding Dangerous Drug-Drug Interactions in Cancer Patients
Food Addiction Prevalence in Patients with Psychiatric Disorders
BCL11A Knockdown Gene Therapy Reactivates Fetal Hemoglobin to Treat Sickle Cell Disease
Lowering the Colorectal Cancer Screening Age From 50 to 45
COVID-19 Outcomes in Patients with Hematologic Malignancies
Managing Sickle Cell Pain Crises and Emerging Curative Therapies
Durable Responses with LCAR-B38M CAR T Cell Therapy in Multiple Myeloma
Phase 2 Trial of Ruxolitinib Decitabine Combination for Blast-Phase Myeloproliferative Neoplasms
Practice-Changing Trials in Colorectal and Gastric Cancer: BEACON, ctDNA, and KEYNOTE-062
Choosing First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer by PD-L1 Status
Multi-Gene Panel Testing for Second Primary Cancers in BRCA1/2-Negative Breast Cancer Patients
Cloud Storage, Photo Backup, and Offline Maps for Mobile Devices
Chemoradiation Improves Outcomes in Early-Stage Small Cell Lung Cancer
Non-Communicable Disease Epidemic
Compassionate Communication in Oncology Patient Care
Delivering Bad News to Patients Using the SPIKES Protocol in Oncology
Fasting Around Chemotherapy to Reduce Toxicity and Improve Efficacy in Oncology